Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Surgical Oncology
HR+
Questions discussed in this category
In light of RxPonder results for postmenopausal women with early stage node positive HR+HER2- breast cancer, when is there a role for full axillary LN dissection to confirm degree of nodal involvement and when would sentinel LN evaluation be sufficient?
How would this affect adjuvant radiation plan in breast conservation therapy patients and mastectomy patients?
1 Answer available
10259
Papers discussed in this category
JAMA, 2011-02-09
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
Related Topics in Surgical Oncology
Breast Cancer
Medical Oncology
Radiation Oncology
Breast Surgery
NCI-CCC Tumor Board Question
Breast Cancer, Non-metastatic
University of Wisconsin
NCI-CCC Breast Tumor Board Question
Genitourinary Cancers
Gastrointestinal Cancers